Impact of expected blood pressure reduction on patient preferences for pharmaceutical and renal denervation treatment
Modeling using patient preference weights predicts that a substantial minority of patients favor an interventional treatment such as renal denervation over initiation or escalation of medications. Awareness of a patient's interest in device-based versus pharmaceutical strategies should inform the shared decision-making process for hypertension treatment.
Authors
- Sidney A. Cohen (ORCID: https://orcid.org/0000-0003-1930-1148)
- Christine Poulos (ORCID: https://orcid.org/0000-0001-7810-3411)
- Vanessa DeBruin
- Michael A. Weber (ORCID: https://orcid.org/0000-0002-8504-0831)
- David E. Kandzari (ORCID: https://orcid.org/0000-0002-0868-6655)
- Atul Pathak (ORCID: https://orcid.org/0000-0001-6151-0096)
Institutions
- SUNY Downstate Health Sciences University (US)
- Princess Grace Hospital Centre (MC)
- Piedmont Atlanta Hospital (US)
- Medtronic (United States) (US)
- RTI Health Solutions (US)
Publication Details
- Journal
- Journal of Hypertension
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1097/hjh.0000000000003872
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00